Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Gross Margin (2020 - 2025)

Cellebrite DI's Gross Margin history spans 6 years, with the latest figure at 84.71% for Q4 2025.

  • Quarterly Gross Margin rose 88.0% to 84.71% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 84.2% through Dec 2025, down 20.0% year-over-year, with the annual reading at 84.2% for FY2025, 20.0% down from the prior year.
  • Gross Margin came in at 84.71% for Q4 2025, up from 83.88% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 85.55% in Q3 2024 to a low of 79.07% in Q2 2022.
  • The 5-year median for Gross Margin is 83.67% (2022), against an average of 83.23%.
  • Year-over-year, Gross Margin crashed -392bps in 2022 and then soared 498bps in 2023.
  • Cellebrite DI's Gross Margin stood at 81.83% in 2021, then increased by 2bps to 83.61% in 2022, then increased by 0bps to 83.96% in 2023, then fell by 0bps to 83.84% in 2024, then grew by 1bps to 84.71% in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Gross Margin are 84.71% (Q4 2025), 83.88% (Q3 2025), and 84.39% (Q2 2025).